antifungal therapy – Page 18

Caspofungin therapy in prosthetic valve endocarditis and candidemia due to itraconazole-resistant Candida glabrata (Nakaseomyces glabratus): A case report

mycolabadmin

A 13-year-old boy developed a serious fungal infection of his heart valve after receiving an artificial valve replacement. The initial antibiotic (itraconazole) did not work because the fungus became resistant, likely by forming a protective biofilm. After identifying the resistant fungus through specialized testing, doctors switched to a different medication called caspofungin. The patient fully recovered with this new treatment and remained healthy during follow-up, showing that combination of precise identification and targeted treatment can overcome antibiotic resistance.

COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis—Results of the Prospective MSG-017 Study

mycolabadmin

A fungal infection caused by Aspergillus commonly occurs in COVID-19 patients on ventilators, affecting about 7% of cases. The study found that having this infection was linked to high death rates, but it was unclear whether the fungal infection itself or the severe COVID-19 caused the deaths. Single positive test results for the fungus are not reliable for diagnosis, and antifungal drugs did not improve survival rates.

Tinea genitalis profunda caused by Microsporum canis: A case report and literature review

mycolabadmin

A 23-year-old woman developed a severe fungal infection in the genital area caused by a fungus normally found on dogs. Her initial antibiotic treatment failed because the infection was actually fungal, not bacterial. After diagnosis through fungal culture, she was successfully treated with antifungal medications, though the infection left some scarring and discoloration. This case highlights how genital fungal infections can be difficult to diagnose because they look similar to bacterial infections.

Cold atmospheric plasma improves antifungal responsiveness of Aspergillus flavus and Fusarium keratoplasticum conidia and mycelia

mycolabadmin

Researchers tested a new treatment called cold atmospheric plasma (CAP) combined with antifungal medications against fungi that cause serious eye infections. CAP, which generates reactive molecules without heat, was found to make antifungal drugs work better against two major fungal pathogens. In some cases, drugs that previously didn’t work started working when combined with CAP. This approach could help treat difficult fungal eye infections that are resistant to standard medications.

The Gcn5 lysine acetyltransferase mediates cell wall remodeling, antifungal drug resistance, and virulence of Candida auris

mycolabadmin

Candida auris is a dangerous fungal infection that resists many standard antifungal drugs. Researchers discovered that a protein called Gcn5 helps this fungus survive both drugs and the body’s immune system. By targeting Gcn5 with a new compound called CPTH2, scientists showed they could make the fungus more vulnerable to standard treatments like caspofungin, suggesting a promising new approach to fighting these infections.

Histoplasma capsulatum as a cause for prolonged pulmonary illness in an immunocompetent returning traveller from Bangladesh

mycolabadmin

A 57-year-old man returning from Bangladesh developed a severe lung infection that lasted several weeks and required hospitalization with breathing support. Doctors initially thought he had tuberculosis or bacterial pneumonia, but standard tests came back negative. Advanced fungal testing eventually identified the cause as histoplasmosis, a fungal infection he likely caught while supervising construction work. After treatment with antifungal medications, the patient recovered and was discharged to continue medication at home for a year.

Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient

mycolabadmin

A 5-year-old girl with a serious joint disease called systemic juvenile idiopathic arthritis developed a dangerous fungal infection in her nasal cavity and brain area. The fungal infection, caused by a mold organism called Lichtheimia, occurred because her immune system was severely weakened by medications used to treat her arthritis. Doctors treated the infection with antifungal drugs and surgery, and the patient eventually recovered by switching to a different arthritis medication. This case highlights how the strong medications needed to control some childhood arthritis can unexpectedly cause serious fungal infections.

The fungal STRIPAK complex: Cellular conductor orchestrating growth and pathogenicity

mycolabadmin

The STRIPAK complex is a cellular control hub found in fungi that acts like a conductor orchestrating multiple cellular processes essential for fungal growth and the ability to cause disease. Scientists have discovered that this complex is highly conserved across different fungal species and regulates critical virulence factors like melanin production and capsule formation in pathogenic fungi. Because the fungal version differs from the human version, it presents a promising target for developing selective antifungal medications. Understanding how STRIPAK works provides insights into how fungi cause infections and could lead to new treatment strategies.

Cracks in the Curriculum: The Hidden Deficiencies in Fungal Disease Coverage in Medical Books

mycolabadmin

This study examined how well major medical textbooks teach doctors and medical students about fungal infections. Researchers found that books focused on infectious diseases do a much better job than general medicine textbooks in covering important information about fungal diseases. Many textbooks lack sufficient information about preventing fungal infections and diagnosing them correctly, which could lead to delayed treatment and poor patient outcomes.

Invasive Saprochaete capitata Infection in an Immunocompromised Patient With Acute Myeloid Leukemia: A Case Report

mycolabadmin

A 46-year-old man with blood cancer developed a serious fungal infection caused by Saprochaete capitata during chemotherapy. This rare but dangerous fungus was found in his blood and lungs, causing fever and breathing problems. The patient was successfully treated with a combination of two antifungal medications and fully recovered, though this infection typically has a high death rate.

Research Keyword: antifungal therapy